Colorectal cancer (CRC) may present in a variety of ways, ranging from incidental findings during routine screening to emergency situations requiring immediate medical intervention. Understanding the spectrum of clinical presentations is critical for timely diagnosis and management.
1. Asymptomatic Presentation
A significant proportion of CRC cases are diagnosed in asymptomatic individuals undergoing routine screening or during evaluation for unrelated medical conditions. These patients are often found to have early-stage disease, underscoring the value of screening protocols.
2. Symptomatic Presentation
The majority of CRC cases (70–90%) are diagnosed after the onset of symptoms, which typically indicate more advanced disease due to tumor growth into the bowel lumen or adjacent structures.
Local Tumor Symptoms
Patients may present with:
• Hematochezia or melena
• Abdominal pain
• Iron deficiency anemia without an apparent cause
• Altered bowel habits (e.g., diarrhea, constipation, narrowing of stool)
Less commonly, symptoms such as abdominal distension, nausea, and vomiting may suggest partial or complete bowel obstruction. A large retrospective cohort study of over 29,000 patients referred for colorectal surgical evaluation revealed the following symptom distribution among 1,626 patients diagnosed with CRC:
• Change in bowel habits (74%)
• Rectal bleeding with change in bowel habits (51% overall, 71% among those with
rectal bleeding)
• Rectal mass (25%) or abdominal mass (13%)
• Iron deficiency anemia (10%)
• Abdominal pain as the sole symptom (4%)
3. Early-Onset CRC Symptoms
The incidence of CRC in individuals under 50 years of age is increasing globally. A systematic review highlighted the following common symptoms in early-onset CRC:
• Hematochezia (45%)
• Abdominal pain (40%)
• Change in bowel habits (27%)
• Weight loss (17%)
• Loss of appetite (15%)
• Constipation (14%)
• Abdominal distension (14%)
• Diarrhea (12%)
• Anemia (11%)
Additional symptoms can include tenesmus, obstruction, rectal pain, fatigue, nausea, vomiting, and palpable masses.
4. Symptom Variability by Tumor Location
The anatomical location of the tumor within the colon influences symptomatology:
• Left-sided tumors are more likely to cause changes in bowel habits due to the narrower lumen and more solid fecal content.
• Right-sided tumors often present with iron deficiency anemia and less frequently with obstructive symptoms due to the larger luminal diameter and liquid stool.
• Rectosigmoid tumors commonly cause hematochezia.
• Rectal cancer may lead to tenesmus, rectal pain, and pencil-thin stools.
• Apple-core lesions, classically seen on barium enema, are indicative of circumferential bowel involvement and are associated with obstructive symptoms.
5. Metastatic Disease
CRC metastasizes via lymphatic, hematogenous, contiguous, and transperitoneal routes. Common metastatic sites include:
• Regional lymph nodes
• Liver (most common due to portal venous drainage)
• Lungs
• Peritoneum
Signs of metastatic disease may include:
• Right upper quadrant discomfort
• Abdominal distension
• Early satiety
• Supraclavicular lymphadenopathy
• Periumbilical nodules
Tumors of the distal rectum may initially metastasize to the lungs, bypassing the liver, due to systemic venous drainage via the inferior rectal vein.
6. Atypical Presentations
CRC may present with unusual features, including:
• Fistula formation into adjacent organs such as the bladder or small intestine, especially in sigmoid or cecal tumors.
• Localized perforation causing intra-abdominal abscesses or systemic infections.
• Fever of unknown origin, abdominal wall or hepatic abscesses.
• Streptococcus bovis or Clostridium septicum bacteremia—found in 10–25% of associated CRC cases.
• Other infections potentially linked to CRC include Fusobacterium nucleatum, colibactin-producing E. coli, and Bacteroides fragilis.
• Adenocarcinomas of unknown primary origin may be traced back to CRC in about 6% of cases.
• Incidental detection of liver metastases during unrelated imaging studies such as renal or gallbladder ultrasounds or CT scans.
Conclusion
Recognizing the broad clinical spectrum of CRC—from asymptomatic screening findings to complex metastatic and atypical presentations—is essential for early diagnosis and effective treatment. Clinicians should maintain a high index of suspicion, particularly in symptomatic individuals or those with risk factors for early-onset CRC.
